Neutrophil adhesion to activated endothelial cells and trans-endothelial migration of these cells are essential events of the innate immune response required for kill invading pathogens and bacterial clearance [4] [5] [6] . While neutrophil recruitment into site of injury is the first-line of defense, excessive neutrophil infiltration and activation at the vessel wall is also the primary cause of inflammation and tissue damage. Neutrophils have been implicated in numerous inflammatory diseases such as acute lung injury, sepsis, and ischemia-reperfusion injury 1, 2, 6, 7 . Studies showed that inhibition of β2 integrins using anti-β2 integrin antibodies blocked adhesion of neutrophils to endothelial cells, and prevented inflammation leading to restored vascular integrity 8 . These studies supported the concept that targeting neutrophils is a useful strategy; however, antibodies have the disadvantage that they induce generalized loss of neutrophil bactericidal function by impairing the ability of circulating neutrophils to adhere and migrate to the infected site 9 .
Nanoparticles have capabilities to carry and deliver therapeutics to desired cells, based on coating of ligands and antibodies to the their surface 3, 10 . For example, promising results have been obtained using nanoparticles for delivery to therapeutics into tumour cells using cell surface antigens as targeting "addresses" 11, 12 . In this report, using real-time intravital microscopy of inflamed post-capillary venules of live mice, the primary site of neutrophil adhesion and extravasation in the circulation 13, 14 , we demonstrate that albumin nanoparticles are internalized by activated neutrophils through endocytosis that is in part mediated by Fcγ receptor III (FcγRIII). Treatment of mice with albumin nanoparticles incorporating piceatannol, an inhibitor for spleen tyrosine kinase (Syk), which blocks 'outside-in' integrin signaling 15 , markedly reduced neutrophil adhesion and migration across the endothelium. Studies in the mouse model of endotoxin-induced acute lung injury mediated by the infiltration of neutrophils also showed that piceatannol-incorporated albumin nanoparticles prevented lung injury.
We first prepared stable albumin nanoparticles by desolvation of bovine serum albumin (BSA) using ethanol, followed by albumin cross-linking using glutaraldehyde ( Supplementary Fig. S1 ) 16 . To study internalization properties of albumin nanoparticles by phagocytes, we incorporated fluorescent dyes in nanoparticles (Supplementary Fig.   S1 ). Studies using transmission electron microscopy ( Supplementary Fig. S2 ) and dynamic light scattering ( Supplementary Fig. S3 ) showed that the size of albumin nanoparticles with and without fluorescent dyes was similar wit mean diameter of 100 ± 10 (SD) nm.
We next employed real-time fluorescence intravital microscopy to study the uptake of albumin nanoparticles by neutrophils 13 . Vascular inflammation was induced by intrascrotal injection of the pro-inflammatory cytokine tumour necrosis factor (TNF-α) in mice. At 3 hr post-TNF-α challenge, cremaster muscle was exposed, and neutrophils adherent to activated venular endothelial cells were monitored. Intravenous injection of Cy5-loaded albumin nanoparticles resulted in the nanoparticles being largely internalized by the leukocytes adherent to the inflamed venular endothelial cells, and to some extent by neutrophils slowly rolling along the vessel wall (Movie 1). However, nanoparticles were not internalized by the TNF-α activated endothelium itself. To confirm that the nanoparticles were primarily internalized by neutrophils, we simultaneously intravenously infused an Alexa Fluor 488-labeled anti-mouse Gr-1 antibody 13 and Cy5-loaded albumin nanoparticles. Anti-mouse Gr-1 antibody and albumin nanoparticles showed marked co-staining ( Fig. 1a and Movie 2). In control experiments, non-immune isotype control antibody, IgG did not show a signal ( Supplementary Fig. S4 ). To address whether albumin nanoparticles can also be internalized by unstimulated neutrophils in the circulation, Cy5-loaded albumin nanoparticles were infused intravenously. Here Cy5-loaded albumin nanoparticles, we failed to detect Gr-1 positive neutrophils (Fig. 1b and Movie 3), indicating that only adherent neutrophils were able to internalize the nanoparticles. We also examined nanoparticle internalization by adherent monocytes, another phagocytic cell involved in inflammation 17 . At 3 hr post-intrascrotal injection of TNF-α, Alexa Fluor 488-labeled anti-mouse F4/80 antibody 17 (which marks for monocytes) and Cy5-loaded albumin nanoparticles were infused intravenously, and monitored. Adherent monocytes, unlike neutrophils, did not internalize albumin nanoparticles (Fig. 1c-d and Movie 4).
To investigate essential determinants of nanoparticle internalization, we compared the uptake of three different types of nanoparticles by activated neutropphil.
In the first two, BSA nanoparticles were made by ethanol-induced albumin desolvation 16, 18 to denature albumin, a process followed by albumin cross-linking to form stable particles (Fig. 2a) . Albumin nanoparticles were then either incorporated with fluorescent dye (Cy5-loaded albumin nanoparticles shown in Fig. 1 ) or their surface was chemically conjugated with Alexa Fluor 647 by carboxyl-amine reaction that forms covalent bonds between Alexa Fluor 647 and albumin nanoparticles (Alexa Fluor 647-conjugated albumin nanoparticles) 19 . Also we fabricated nanoparticles in which yellowgreen fluorescence polystyrene nanoparticles with diameter of 100 nm were coated with native BSA (albumin-conjugated polystyrene nanoparticles) 19 . Comparing the uptake of these two types of albumin nanoparticles by Gr-1 positive neutrophils following intravenous infusion at 3 hr after intrascrotal injection of TNF-α, we observed that Alexa Fluor 647-conjugated albumin nanoparticles were internalized by the adherent neutrophils and showed characteristic punctual distribution in the cytosol whereas Cy5-loaded albumin nanoparticles showed diffuse fluorescence throughout the cell ( Comparing the fluorescence intensities of internalized Cy5-loaded nanoparticles with Cy5-conjugated nanoparticles, uptake efficiency of two types of albumin nanoparticles was similar (Fig. 2d) . Further, we observed that the general morphology of the adherent neutrophils internalizing either type of nanoparticle was the same and cells had similar surface area of 54 ± 6 (mean ± SD) µm 2 . Unlike nanoparticles made from denatured albumin, native albumin-conjugated polystyrene nanoparticles remained bound to the surface of neutrophils without internalizing ( Fig. 2e and Movie 6). We also did not observe uptake of albumin itself following intravenous infusion of Cy5 conjugated to albumin (Fig. 2f) . As quantified by multiple images, 95% of all adherent neutrophils similarly internalized either dye-loaded or dye-conjugated albumin nanoparticles. In contrast, neither albumin-conjugated polystyrene particles nor Cy5-conjugated albumin was internalized by the adherent neutrophils (Fig. 2g ).
FcγRs bind IgG-opsonized particles and denatured proteins, and activate endocytosis 14 . Thus, we investigated whether nanoparticles made of denatured albumin could be internalized through FcγR signaling. Using neutrophils obtaining from FcγRIII -/-mice, we observed that uptake of albumin nanoparticles was significantly reduced compared to wild-type (WT) (Fig. 3a) . On measuring fluorescence intensity of Cy5-loaded albumin nanoparticles per neutrophil, we obtained a distribution of nanoparticle uptake per neutrophil (Fig. 3b) . FcγRIII contributed to ~50% of total uptake of albumin nanoparticles (Fig. 3g) , consistent with the role of FcγR signaling as a mechanism of immune complex internalization by neutrophils 20 . The basis of residual uptake is unclear but may involve other Fcγ receptors 21 . Macrophage antigen-1 (Mac-1 or αMβ2 integrin) and lymphocyte function-associated antigen-1 (LFA-1 or αLβ2 integrin) mediate neutrophil adhesion during vascular inflammation and denatured albumin binds to Mac-1 and may contribute to uptake of denatured proteins 14 ; however, we observed that deletion of Mac-1 and LFA-1 had no effect on uptake of albumin nanoparticles ( Fig. 3c-g ).
We next examined whether albumin nanoparticles loaded with the Syk inhibitor, piceatannol 15 , could reverse the TNF-α-mediated firm adhesion of neutrophils to venular endothelial cells, and thus mitigate inflammation. Syk signaling is crucial in the mechanism of 'outside-in' integrin signaling that mediates β2 integrin-dependent neutrophil adhesion, spreading, and migration 15, 22 . Piceatannol selectively inhibits Syk activity but it is an ineffective due to water solubility 23 . We investigated whether piceatannol could be loaded into albumin nanoparticles for delivery into adherent neutrophils ( Supplementary Fig. S5 ). In this study, most neutrophils adhered to the endothelium, although few rolling neutrophils were also seen ( Fig. 4a and Movie 7).
Intravenous infusion of piceatannol-loaded albumin nanoparticles, 1 mg/kg body weight of piceatannol (50 µM), significantly reduced the number of adherent neutrophil and concomitantly increased the number of rolling cells (Fig. 4b-c and Movie 8). In controls, albumin nanoparticles alone had no effect (Fig. 4d) .
To investigate further the mechanisms of action of piceatannol-loaded albumin nanoparticles, the flow chamber assay was used in which mouse neutrophils interacted with a monolayer of TNF-α-activated mouse lung endothelial cells under shear condition. In control experiments, Cy5-loaded albumin nanoparticles were internalized by Gr-1 positive neutrophils as in mouse venular studies above. The nanoparticle signal was slightly increased in neutrophils stimulated with N-formyl methionyl peptide, formylmethionyl-leucyl phenylalanine (fMLF) (Supplementary Fig. S6 ). However, treatment of neutrophils with piceatannol-loaded albumin nanoparticles, 800 µg/ml (200 μM as piceatannol) under shear condition markedly reduced β2 integrin-mediated neutrophil spreading and migration across TNF-α-activated endothelial cells and inhibited neutrophil adhesion (Fig. 4e) . Thus, piceatannol-loaded albumin nanoparticles functioned by inhibiting β2 integrin-mediated 'outside-in' signaling through Syk signaling, consistent with the known function of Syk 15 . Syk phosphorylation in fMLF-stimulated neutrophils was also abrogated in neutrophils internalizing piceatannol-loaded albumin nanoparticles (Fig. 4f) indicating that the drug loaded into nanoparticles blocked Syk activity. We performed the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay 24 to eliminate possible drug toxicity effect. Incubating neutrophils with piceatannol-loaded albumin nanoparticles, 800 µg/ml (200 μM as piceatannol), did not affect cell viability (Fig. 4g) . Thus, piceatannol-loaded albumin nanoparticles inhibited Syk phosphorylation, and thereby impaired β2 integrin-mediated 'outside-in' signaling required for neutrophil spreading and migration.
Excessive accumulation of neutrophils in lungs is a major factor in the pathogenesis of acute lung injury associated with sepsis 25 . We showed that β2 integrindependent neutrophil adhesion to lung endothelial cells 26 contributes to acute lung (Fig. 4h, Fig. 4i , and Supplementary Fig.   S7 ). Infiltration of both neutrophils and monocytes determined by bronchoalveolar lavage (BAL) was also reduced by treating mice with piceatannol-loaded albumin nanoparticles (4.3 mg/kg body weight as piceatannol) (Fig. 4j) . Comparison of MPO activity in LPS-induced lung inflammation after administration of piceatannol-loaded albumin nanoparticles and piceatannol (free drug) alone also showed that piceatannolloaded nanoparticles were far more efficacious than piceatannol (Fig. 4k) . Since as shown above albumin nanoparticles are preferentially internalized by neutrophils in vivo, these results demonstrate that impaired neutrophil infiltration in lungs by piceatannolloaded albumin nanoparticles is essential for inhibiting monocyte infiltration. These results also showed the utility of albumin nanoparticle loading of piceatannol for the treatment of acute lung injury.
In summary, we demonstrated an albumin nanoparticle approach for the delivery of drugs into inflammatory neutrophils adherent to endothelial cells that is in part dependent on FcγRIII signaling. Adhesion of neutrophils to activated endothelial cells was required for the internalization of albumin nanoparticles. Since FcγRs are highly expressed in adherent neutrophils during inflammation and vascular diseases 27 , nanoparticles made of denatured albumin can be used to target inflammatory neutrophils while sparing the essential host-defense function of circulating neutrophil.
This strategy limits the undesirable effects of globally blocking the essential bactericidal function of neutrophils. Further, we suggest the feasibility of using albumin nanoparticles to target activated neutrophils without conjugating ligands or antibodies to the nanoparticle surface 3, 10 . The results hence provide the proof-of-concept of a novel nanoparticle-based therapeutic approach for targeting activated neutrophils to treat a range of inflammatory disorders.
Methods

Preparation of albumin nanoparticles loaded with fluorescent dyes or
piceatannol. BSA (bovine serum albumin) nanoparticles were prepared by the desolvation technique ( Supplementary Fig. S1 ) 16 . BSA was first dissolved at a concentration of 20 mg/ml in deionized water. BSA solution, 1 ml, was used to make nanoparticles by the continuous addition of 3.5 ml of ethanol under stirring (650 rpm) for 10 min at RT. In some experiments, BSA solution at 20 mg/ml (1 ml) was mixed and incubated with 40 µl of Cy5 dye (5 mg/ml) in chloroform for 1 hr, followed by desolvation with ethanol. To make piceatannol-loaded albumin nanoparticles, 1 ml of 20 mg/ml of BSA solution was incubated with 1 mg of piceatannol dissolved in DMSO for 1 hr. To form stable albumin nanoparticles with or without a dye or piceatannol, BSA molecules were cross-linked by adding 20 µl of 0.2% glutaraldehyde in the suspension. The suspension was stirred overnight at RT. Nanoparticle suspension was centrifuged at 14,000 rpm for 20 min at 4°C. After drying albumin nanoparticles, we obtained 80-90% albumin to form the nanoparticles. The nanoparticle pellet was re-suspended in water or phosphate-buffered saline, pH 7.4 for the study.
To measure the efficiency of piceatannol incorporation in BSA nanoparticles, different concentrations of piceatannol were added in the initial albumin solution. After centrifugation of suspension of piceatannol-loaded BSA nanoparticles at 14,000 rpm at 4°C for 30 min, the supernatant (containing unbound piceatannol) was collected and centrifuged using Microcon (10-kD cut-off) to separate unbound piceatannol from free BSA molecules. Piceatannol molecules were quantified by measuring the absorbance at 328 nm as shown in Supplementary Fig. S5 . The loading yield of piceatannol in To conjugate covalently Alexa Fluor-647 or Cy5 dye to albumin nanoparticles, we used the carboxyl-amine reaction between dye and albumin 19 . After albumin nanoparticles were made using the desolvation method as described above, we mixed Alex Fluor 647-NHS with albumin nanoparticles, and incubated the mixture for 2 hr at RT. We centrifuged albumin nanoparticles to remove free dye molecules to obtain Alexa Fluor 647-conjugated albumin nanoparticles.
Real-time fluorescence intravital microscopy. In vivo intravital microscopy was performed as described 13 . TNF-α (0.5 µg in 250 μl saline) was intrascrotally injected into wild-type (WT) or knockout mice. At 3 hr after TNF-α injection, mice were anesthetized with intraperitoneal injection of the mixture of ketamine (80 mg/kg), xylazine (2 mg/kg), and acepromazine (2 mg/kg) and maintained at 37°C on a thermo-controlled rodent blanket and a tracheal tube was inserted. After excision of the scrotum, cremaster muscles were exteriorized on the intravital microscope table. The cremaster preparation was superfused with thermo-controlled (37°C) and aerated (95% N 2 , 5% CO 2 ) bicarbonate-buffered saline during the experiment. Fluorescently-labeled albumin nanoparticles (100 µg) in 100 µl of saline were infused through a cannula placed in a Intravital microscopy was performed in mice as described in Fig. 1 
